Cryofocus Medtech (Shanghai) Co (HKSE:06922) Equity-to-Asset : 0.80 (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Cryofocus Medtech (Shanghai) Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Cryofocus Medtech (Shanghai) Co's Total Stockholders Equity for the quarter that ended in Jun. 2023 was HK$224.69 Mil. Cryofocus Medtech (Shanghai) Co's Total Assets for the quarter that ended in Jun. 2023 was HK$280.75 Mil. Therefore, Cryofocus Medtech (Shanghai) Co's Equity to Asset Ratio for the quarter that ended in Jun. 2023 was 0.80.

The historical rank and industry rank for Cryofocus Medtech (Shanghai) Co's Equity-to-Asset or its related term are showing as below:

HKSE:06922' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.68 Med: 0.75 Max: 0.8
Current: 0.76

During the past 4 years, the highest Equity to Asset Ratio of Cryofocus Medtech (Shanghai) Co was 0.80. The lowest was 0.68. And the median was 0.75.

HKSE:06922's Equity-to-Asset is ranked better than
67.97% of 868 companies
in the Medical Devices & Instruments industry
Industry Median: 0.65 vs HKSE:06922: 0.76

Cryofocus Medtech (Shanghai) Co Equity-to-Asset Historical Data

The historical data trend for Cryofocus Medtech (Shanghai) Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryofocus Medtech (Shanghai) Co Equity-to-Asset Chart

Cryofocus Medtech (Shanghai) Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Equity-to-Asset

0.68

0.74

0.76

Cryofocus Medtech (Shanghai) Co Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial			0.74	-	0.76	0.80	0.76

Competitive Comparison of Cryofocus Medtech (Shanghai) Co's Equity-to-Asset

For the Medical Devices subindustry, Cryofocus Medtech (Shanghai) Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cryofocus Medtech (Shanghai) Co's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cryofocus Medtech (Shanghai) Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Cryofocus Medtech (Shanghai) Co's Equity-to-Asset falls into.

Cryofocus Medtech (Shanghai) Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Cryofocus Medtech (Shanghai) Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Equity to Asset (A: Dec. 2022 )	=	Total Stockholders Equity	/	Total Assets
	=	267.044	/	350.495
	=	0.76

Cryofocus Medtech (Shanghai) Co's Equity to Asset Ratio for the quarter that ended in Jun. 2023 is calculated as

Equity to Asset (Q: Jun. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	224.69	/	280.749
	=	0.80

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Cryofocus Medtech (Shanghai) Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Cryofocus Medtech (Shanghai) Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Building 15, Lane 3399, Kangxin Road, Pudong New Area, Shanghai, CHN, 200120

Website

https://www.cryofocus.com

Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture and sale of cryoablation minimally-invasive interventional treatment technology and related medical products. It has two Core Products, the Bladder Cryoablation System and the Endoscopic Clip for Anastomosis. The Bladder Cryoablation System is a cryotherapy device designed for the treatment of bladder cancer. The Endoscopic Clip for Anastomosis is an anastomotic device for the closure of soft tissue in the digestive tract, which is one of the over-the-scope clips. Geographically company's key revenue is generated from China.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Headlines

No Headlines